Medical Doctor Program year 2025 Reported 2022–2025 Source: CMS Open Payments, 2026 publication

Rosa Alers Talavera

Colon & Rectal Surgery San Juan, PR Medical Doctor

NPI 1871034868 CMS profile 8591264

735 Ave Ponce De Leon, Ste 218, San Juan, PR 00917

Open in the dashboard

General payments

$4,081

21 records reported · program years 2022–2025

Research payments

$0

Paid to them · None reported · program years 2022–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Rosa Alers Talavera of San Juan, PR is reported in the CMS Open Payments database as having received $4,081 across 21 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 58th percentile of Colon & Rectal Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

4 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $2,898 10
2024 General $943 8
2023 General $125 1
2022 General $114 2

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Rosa Alers Talavera
  • Colon & Rectal Surgery median
  • Middle half of Colon & Rectal Surgery
  • National median

In program year 2025, general payments to Rosa Alers Talavera were reported at $2,898. Among 1,481 Colon & Rectal Surgery profiles paid that year, the median was $317 and the middle half received between $109 and $1,248.

Show as a table
Year Rosa Alers Talavera Colon & Rectal Surgery median Middle half National median
2019 $0 $443 $125–$2,179 $163
2020 $0 $167 $53–$931 $114
2021 $0 $207 $72–$1,272 $132
2022 $114 $341 $111–$1,587 $149
2023 $125 $322 $115–$1,420 $160
2024 $943 $328 $112–$1,354 $164
2025 $2,898 $317 $109–$1,248 $169

Breakdown

Who paid General payments · program years 2022–2025
  1. Intuitive Surgical, Inc. $1,029 2 payments
  2. Applied Medical Resources Corporation $928 2 payments
  3. Stryker Corporation $445 2 payments
  4. Davol Inc. $402 2 payments
  5. THD America, Inc. $362 1 payment
  6. Acera Surgical, Inc. $275 2 payments
  7. Boston Scientific Corporation $187 3 payments
  8. Medtronic, Inc. $159 3 payments
  9. Integra LifeSciences Corporation $138 1 payment
  10. W. L. Gore & Associates, Inc. $113 1 payment
  11. Other $43 2 payments

Every payment, record by record

What the payments were for General payments · program years 2022–2025
  1. Food and Beverage $1,563 17 payments
  2. Education $1,295 2 payments
  3. Travel and Lodging $1,223 2 payments
Products named General payments · program years 2022–2025
  1. DAVINCI XI $1,000 1 payment
  2. Gelport Laparoscopic System $928 2 payments
  3. Phasix Mesh $402 2 payments
  4. Restrata Wound Matrix $275 2 payments
  5. Symbotex $159 3 payments
  6. 1788 $150 1 payment
  7. Integra Recon-Skin And Wound $138 1 payment
  8. Integra Recon-Skin And Wound $138 1 payment
  9. Integra Recon-Skin And Wound $138 1 payment
  10. INTEGRA DERMAL REGENERATION TEMPLATE $138 1 payment
  11. Other $554 10 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

21 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Colon & Rectal Surgery in Puerto Rico

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record